Barron's claims that:
"If 60 million Americans got the weight-loss drugs and 90% of them benefited, that could translate to over a 1% boost to U.S. GDP from the bigger labor force and higher productivity"
Reference:
https://www.barrons.com/articles/why-ozempic-could-power-the-nations-gdp-234b346e
This market turns true if by 2030:
It's been empirically proven that the impact of obesity drug has led to at least 1% yearly GDP growth improvement in the USA, or
60 million Americans got the weight-loss in 2030, AND expert consensus seems to validate this growth claim. [In case of uncertain outcome, we may validate it through a manifold poll]
@Retr0id that's why I included the second point, if we reach 60m yearly users and evidence points in the right direction it should be ok, or at least enough to have a poll on it
@SimoneRomeo sure, I'm predicting that even if it comes down to a poll, it may be difficult to convince poll participants of the correlation - could go either way of course, hence my small bet :)